• Upcoming Events

     
  • New Members

     
  • ECRMC to participate in drug trial

    • Share:
    June 19, 2020

    EL CENTRO – El Centro Regional Medical Center announced Thursday it is participating in a clinical trial to test the therapeutic value of an anti-inflammatory drug that has shown promise in the treatment of COVID-19 pneumonia.

    This trial will study the drug tocilizumab, sold under the brand name Actemra, and evaluate its safety and efficacy in the treatment of patients with severe COVID-19 pneumonia. Tocilizumab is an approved treatment for rheumatoid arthritis and other inflammatory disorders.